Canary Staked INJ ETF: What INJC Offers Investors

This article is brought to you by Injective.

INJC puts two things into one brokerage ticker: exposure to Injective’s native token, INJ, and staking handled inside the fund. The Canary Staked INJ ETF began trading on Nasdaq on November 5, 2026. Its structure gives investors a way to hold a fund backed by spot INJ without setting up a crypto wallet or selecting a validator.

That convenience comes with a clear trade-off. INJC shareholders don’t own or control the underlying tokens directly, so they can’t vote in Injective governance or use INJ in onchain applications. Staking rewards accumulate within the fund rather than arriving as cash distributions.

What INJC changes for investors

The fund is sponsored by Canary Capital Group LLC and holds INJ itself. Under normal conditions, it intends to stake at least 90% of its INJ through third-party staking providers. BitGo Bank & Trust, N.A. holds the keys to the fund’s INJ.

For investors who already use a brokerage account, the operating model is familiar: shares trade in U.S. dollars during U.S. market hours. INJ, by contrast, trades around the clock on crypto exchanges. INJC shares can be sold on the exchange, while directly staked INJ must be unstaked before it can be transferred or sold. The source comparison says that process takes 21 days.

The launch gives INJ a place among a small group of digital assets available through U.S. spot ETFs. Before INJC, the source described about 15 such assets, including bitcoin, ether, Ripple, Solana and Chainlink. It placed INJ at roughly number 16 among tokens tracked by CoinGecko that U.S. investors could access through a spot ETF.

Injective has also been building connections with traditional financial services. The milestones below provide context for INJC’s arrival:

How staking rewards work

Injective validators help run and secure the network. INJC delegates most of its INJ to third-party staking providers, and the rewards are added to the fund rather than paid to shareholders. As rewards accumulate, each share represents a larger amount of INJ. There’s no separate cash payout.

Injective Hub recently reported a staking reward rate of roughly 7% a year. That rate depends on how much INJ is staked across the network, so it can change and isn’t guaranteed. A hypothetical holding backed by 100 INJ illustrates how a steady 7% annual rate would compound:

This illustration leaves out fund expenses and doesn’t predict INJC’s returns. More INJ per share also doesn’t guarantee a gain in dollar value: the fund’s value remains tied to INJ’s market price, which can rise or fall by more than staking adds.

Source: Injective Hub.

The asset behind the ticker

Injective is a blockchain designed for financial applications. Projects on the network enable people and agents to trade crypto, public and pre-IPO stocks, commodities and foreign exchange onchain. The source names Pentiv and POSCO International as companies using Injective to bring real-world assets such as mortgage records and trade receivables onto the blockchain.

INJ serves three roles in the network: it pays transaction fees, can be staked to help secure the chain, and gives stakers voting rights on network proposals and upgrades. Injective also runs a monthly Community BuyBack. Participants commit INJ in return for a share of ecosystem revenue, and the committed tokens are burned.

INJC gives shareholders price exposure to INJ through fund shares. It doesn’t transfer those network functions to them. Shareholders can’t cast governance votes with the fund’s staked tokens, put their shares to work in Injective applications or take part in the BuyBack.

Fund details and direct ownership

A share’s dollar price won’t necessarily match INJ’s token price. Each share has its own price based on the fund’s starting share value and the amount of INJ represented by each share. Percentage changes offer a more useful comparison than the two price tags.

Source: Canary Staked INJ ETF Form S-1/A, October 23, 2026; final terms in the INJC prospectus.

Direct INJ ownership offers more control: holders can choose a validator, vote with staked tokens, trade at any hour and use INJ across Injective applications. INJC instead keeps the holding inside a brokerage account, with the fund handling custody and staking. The better fit depends on whether brokerage access or direct onchain control matters more to the holder.

Source: Injective, "INJ Tokens and INJ ETF Shares Compared" and the INJC prospectus.

Trading hours, access and risks

Investors can search for INJC through a brokerage account that offers Nasdaq-listed ETFs. Availability depends on the broker, account type and country. Shares trade from 9:30 a.m. to 4:00 p.m. ET on weekdays, along with any extended hours a broker supports. The minimum purchase is one share, unless the broker offers fractional shares. Retirement-account eligibility also depends on the broker.

INJ continues trading through weekends, while INJC does not. A weekend move in the token can therefore leave the ETF opening Monday at a noticeably different price from Friday’s close. New funds can also have wider gaps between bid and ask prices; a limit order lets a buyer set the maximum price they’ll pay.

The fund structure removes wallet and validator management, but exposure to INJ’s price remains. The source lists several risks for investors to weigh:

• INJ price volatility: The token can move sharply in either direction, and investors could lose some or all of their money.

• Staking and validator risk: Validator errors or outages can lead to penalties that reduce the fund’s INJ. Reward rates can also change and aren’t guaranteed.

• Trading gaps: INJ trades every day, while INJC trades during market hours. Weekend developments may be reflected in the ETF only when trading resumes.

• Changing rules: The source notes that U.S. rules for crypto ETFs and staking within them are still developing.

Shareholders can’t redeem INJC shares for INJ; the shares trade for dollars on Nasdaq. The full risk disclosures and fund terms are available in the INJC prospectus.

What INJC signals

INJC gives investors and financial advisers a way to add INJ exposure through a standard brokerage account, with staking performed inside the fund. That may widen access for people who don’t want to manage crypto custody themselves. For holders who want governance rights, around-the-clock trading or access to Injective’s onchain applications, direct ownership still offers capabilities the ETF doesn’t.

The fund’s significance lies in that change of access: INJ now has a Nasdaq-listed product that combines spot exposure with staking. Its practical appeal will depend on whether investors value brokerage convenience enough to give up direct use and control of the tokens.

This article is sponsored content brought to you by Injective. It is for informational purposes only and is not investment, tax or legal advice, or an offer to buy or sell any security. Read the INJC prospectus, including its risk factors, before investing.